Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Por um escritor misterioso
Descrição
Frontiers Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Neoadjuvant immunotherapy improves outlook in
Frontiers Adjuvant immunotherapy in early-stage resectable non–small cell lung cancer: A new milestone
Neoadjuvant or adjuvant immunotherapy in melanoma stage iii
Episode 1: The Role of Adjuvant and Neoadjuvant Therapy in Melanoma
Novel adjuvant options for cutaneous melanoma - ScienceDirect
Adjuvant and neoadjuvant therapy for cutaneous melanoma - UpToDate
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma☆ - Annals of Oncology
